Gennova is a ₹49-crore company and it mRNA business, at ₹6.47 crore, represented 0.71% of consolidated revenue of the company of ₹911.58 crore, Emcure said

Emcure's Gennova transfers its mRNA business to Immunoscript Life Science for ₹139 crore, focusing on core biotech operations.

Gennova is a ₹49-crore company and it mRNA business, at ₹6.47 crore, represented 0.71% of consolidated revenue of the company of ₹911.58 crore, Emcure said